SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-216024
Filing Date
2021-07-15
Accepted
2021-07-15 09:40:02
Documents
14
Period of Report
2021-07-15
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d358491d8k.htm   iXBRL 8-K 39787
2 EX-3.1 d358491dex31.htm EX-3.1 6616
3 EX-3.2 d358491dex32.htm EX-3.2 137851
  Complete submission text file 0001193125-21-216024.txt   347024

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cnst-20210715.xsd EX-101.SCH 2924
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnst-20210715_lab.xml EX-101.LAB 18889
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnst-20210715_pre.xml EX-101.PRE 11881
7 EXTRACTED XBRL INSTANCE DOCUMENT d358491d8k_htm.xml XML 3623
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Filer) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38584 | Film No.: 211091863
SIC: 2834 Pharmaceutical Preparations